Nonrenal Elevation of Cystatin C Mimicking AKI After Allogeneic Stem-Cell Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1239; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received methylprednisolone, ruxolitinib, tocilizumab, anakinra, and etanercept for refractory cytokine storm. Neither creatinine nor cystatin C-based eGFR was reliable in this critically ill patient; the combined CKD-EPI equation was also misleading due to disproportionate cystatin C elevation. Clinicians should integrate multiple GFR estimation methods, including measured CrCl, and recognize non-GFR determinants of both biomarkers when assessing kidney function in post-transplant critically ill patients."
Chronic Kidney Disease • Genetic Disorders • Graft versus Host Disease • Hematological Malignancies • Immunology • Leukemia • Nephrology • Obesity • Respiratory Diseases • Transplantation • CST3
|
|
Saad Abdulrahim Talal Mahmoud; Hadeel Jazieh; Abedalrahman Almashayekh; Joseph H. Holthoff
|